[Close]
- This page was created by volunteers like you!
- Help us make it even better. To learn more about contributing to MEpedia, click here.
- Join the movement
- Visit #MEAction to find support or take action. Donate today to help us improve and expand this project.
- Congratulations!
- MEpedia has got over 30 million views as of August 2022!
Fingolimod
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
 | This article is a stub. |
Fingolimod or Gilenya (brand name) is a drug licensed for use in adults and children aged over 20 with relapsing-remitting multiple sclerosis.[1] Fingolimod may module TRPM7.
Theory[edit | edit source]
Evidence[edit | edit source]
Clinicians[edit | edit source]
Risks and safety[edit | edit source]
No clinician trials have been conducted for ME/CFS patients using fingolimod.
Costs and availability[edit | edit source]
Perscription only drug.
See also[edit | edit source]
Learn more[edit | edit source]
- Fingolimod - Uses, Side Effects, Warnings - drugs.com
- Fingolimod - MedlinePlus
- Fingolimod - FDA perscribing information - drugs.com
- Fingolimod - PubChem
